Results 31 to 40 of about 9,893 (203)

Accurate subspecies-level identification of clinically significant Mycobacterium avium and Mycobacterium intracellulare by whole-genome sequencing [PDF]

open access: yes, 2023
Whole genome sequencing (WGS) of Mycobacterium avium complex (MAC) isolates in the clinical laboratory setting allows for rapid and reliable subspecies identification of a closely related complex of human pathogens. We developed a bioinformatics pipeline
Omai B. Garner   +13 more
core   +1 more source

Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
ObjectivesThis study summarizes the epidemiological characteristics, species distribution, and drug sensitivity of clinical nontuberculous mycobacteria (NTM) isolates at the Public Health Clinical Center of Chengdu, China, from January 2017 to December ...
Dong-Mei Wang   +4 more
doaj   +1 more source

Acute and persistent Mycobacterium tuberculosis infections depend on the thiol peroxidase TpX. [PDF]

open access: yes, 2009
The macrophage is the natural niche of Mycobacterium tuberculosis infection. In order to combat oxidative and nitrosative stresses and persist in macrophages successfully, M. tuberculosis is endowed with a very efficient antioxidant complex.
Hu, Y   +4 more
core   +1 more source

Skin and soft tissue infection by Mycobacterium intracellulare in an immunocompetent patient

open access: yesIDCases, 2020
Nontuberculous mycobacteria (NTM) infections still represent a large group of insidious diseases hard to deal with. Traditionally, immunocompromised patients suffer from NTM infections, especially with respiratory involvement or disseminated diseases due
Alessio Pampaloni   +9 more
doaj   +1 more source

Discovery of Nosiheptide, Griseoviridin, and Etamycin as Potent Anti-Mycobacterial Agents against Mycobacterium avium Complex

open access: yesMolecules, 2019
Mycobacterium avium complex (MAC) is a serious disease mainly caused by M. avium and M. intracellulare. Although the incidence of MAC infection is increasing worldwide, only a few agents are clinically used, and their therapeutic effects are limited ...
Kanji Hosoda   +3 more
doaj   +1 more source

A rhodanine agent active against non-replicating intracellular Mycobacterium avium subspecies paratuberculosis. [PDF]

open access: yes, 2009
BACKGROUND: Antibiotic therapy targeting chronic mycobacterial disease is often ineffective due to problems with the emergence of drug resistance and non-replicating persistent intracellular antibiotic resistant phenotypes.
Hermon-Taylor, J   +11 more
core   +1 more source

Exploring the Zoonotic Potential of Mycobacterium avium Subspecies paratuberculosis through Comparative Genomics. [PDF]

open access: yes, 2011
A comparative genomics approach was utilised to compare the genomes of Mycobacterium avium subspecies paratuberculosis (MAP) isolated from early onset paediatric Crohn's disease (CD) patients as well as Johne's diseased animals.
Michalski Wojtek P.   +32 more
core   +1 more source

Mycobacterium intracellulare induces a Th17 immune response via M1-like macrophage polarization in canine peripheral blood mononuclear cells

open access: yesScientific Reports, 2022
Mycobacterium avium-intracellulare complex (MAC) is one of the most prevalent pathogenic nontuberculous mycobacteria that cause chronic pulmonary disease.
Suji Kim   +4 more
doaj   +1 more source

Лекарственная чувствительность клинических изолятов Mycobacterium avium complex [PDF]

open access: yes, 2022
The objective: to study drug susceptibility of M. avium and M. intracellulare isolates received from patients with mycobacteriosis residing in the North Western Federal District using the Sensititre SLOMYCO panels.Subjects and Methods. From 2014 to 2020,
D. A. Starkova   +5 more
core   +2 more sources

Regional and temporal changes in AIDS in Europe before HAART [PDF]

open access: yes, 2002
In a prospective observational study 4485 patients from 46 clinical centres in 17 European countries were followed between April 1994 and November 1996.
Fätkenheuer, G.   +25 more
core   +1 more source

Home - About - Disclaimer - Privacy